← All indications
Positron-Emission Tomography
An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower.
Subtype terms (1)
More specific conditions that are subtypes of Positron-Emission Tomography in the MeSH hierarchy.
- Positron Emission Tomography Computed Tomography
19 drugs (9 approved, 10 experimental)
Drugs by status
Approved for this indication (2)
Phase 4 trials (2)
Phase 3 trials (10)
Phase 2 trials (6)
Phase 1 trials (20)
Other trials (2)